跳至主要内容
临床试验/CTRI/2024/09/073208
CTRI/2024/09/073208尚未招募不适用

Anonymized patient survey on hepatocellular carcinoma (HCC) surveillance practices in India

Tata Memorial Hospital1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2024年9月11日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
500
试验地点
1
主要终点
- To determine the frequency of prior ultrasound examination, 6-months prior to detection

研究概览

简要总结

Patients at risk of developing hepatocellular carcinoma, particularly those with cirrhosis of liver,

are advised to have six-monthly surveillance by ultrasound examination. However, the effect of

implementation of this recommendation on the detection of hepatocellular carcinoma in India is

not known.Therefore, a representative patient survey will be conducted and coordinated by

VPS Lakeshore hospital to determine the frequency of prior ultrasound examination, 6-months prior to detection

of hepatocellular carcinoma.Also, to determine the stage of hepatocellular carcinoma (Milan criteria) at the

time of detection of hepatocellular carcinoma.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 90.00 Year(s)(—)
性别
All

入选标准

  • Only adult patients more than equal to 18 years.
  • who speak English Hindi and Marathi.
  • who are receiving a diagnosis and are undergoing evaluation or treatment of HCC at TMH Mumbai will be included.

排除标准

  • Patient not willing for Informed Consent.
  • Who are Minors.

结局指标

主要结局

- To determine the frequency of prior ultrasound examination, 6-months prior to detection

时间窗: Baseline

of hepatocellular carcinoma.

时间窗: Baseline

次要结局

  • - To determine the stage of hepatocellular carcinoma (Milan criteria) at the time of detection of hepatocellular carcinoma.(Baseline)

研究者

申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Prachi Patil

Tata Memorial Hospital

研究点 (1)

Loading locations...

相似试验